| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.096 | 0.04 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |